| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |